Suppr超能文献

静脉曲张硬化治疗后食管的内镜异常——一项长期随访研究

Endoscopic abnormalities in the oesophagus after variceal sclerotherapy--a long-term follow up study.

作者信息

Thomas Varghese, Tony Jose, Harish K, Harikumar R, Sunilkumar K

机构信息

Department of Gastroenterology, Medical College Hospital, Calicut - 673 008, Kerala, India.

出版信息

Trop Gastroenterol. 2007 Jan-Mar;28(1):24-7.

Abstract

Endoscopic sclerotherapy is a well-established treatment modality for oesophageal varices. Various local, regional and systemic complications occur after sclerotherapy. Altered endoscopic appearances of the oesophagus have been observed on follow-up of patients after sclerotherapy. 171 consecutive patients with extra-hepatic portal venous obstruction on follow up after achieving variceal eradication by sclerotherapy during the period from January 2004 to June 2005 were enrolled in this study. The oesophagus was closely observed for mucosal abnormalities and the endoscopic findings were recorded. Out of 171 patients, 95 (55.5%) patients had no specific endoscopic changes in the oesophagus. The most common finding was mucosal neovascularization which was seen in 56 (32.7%) patients. Oval or oblong depressed areas were seen in 41 (23.9%) patients. Mucosal tags and polypoidal lesions were seen in 37 (21.6%) patients. 25 (15.6%) patients had stenosis of the lower oesophagus and 3 (1.7%) patients had mucosal bridges. On multivariate analysis, these abnormal endoscopic findings in the oesophagus correlated with the total volume of sclerosant injected when compared with those patients without similar findings on endoscopy (p value < 0.001). Endoscopic sclerotherapy leads to various abnormalities at the injection sites like neovascularization, oval or oblong depressed areas, mucosal tags, polypoidal lesions, stenosis and mucosal bridges. Endoscopic abnormalities correlated with the total volume of sclerosant used. The long-term significance of these changes is not known at present and further follow-up studies will be required.

摘要

内镜下硬化疗法是治疗食管静脉曲张的一种成熟的治疗方式。硬化疗法后会出现各种局部、区域和全身并发症。在硬化疗法后的患者随访中观察到食管内镜表现发生了改变。本研究纳入了2004年1月至2005年6月期间经硬化疗法消除静脉曲张后进行随访的171例肝外门静脉阻塞患者。密切观察食管黏膜异常情况并记录内镜检查结果。171例患者中,95例(55.5%)食管内镜检查无特异性改变。最常见的表现是黏膜新生血管形成,见于56例(32.7%)患者。41例(23.9%)患者可见椭圆形或长方形凹陷区。37例(21.6%)患者可见黏膜赘生物和息肉样病变。25例(15.6%)患者有食管下段狭窄,3例(1.7%)患者有黏膜桥形成。多因素分析显示,与内镜检查无类似表现的患者相比,食管这些异常内镜表现与硬化剂注射总量相关(P值<0.001)。内镜下硬化疗法会导致注射部位出现各种异常,如新生血管形成、椭圆形或长方形凹陷区、黏膜赘生物、息肉样病变、狭窄和黏膜桥形成。内镜异常与所用硬化剂总量相关。目前尚不清楚这些改变的长期意义,需要进一步的随访研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验